Advaxis Inc
F:FAD2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Advaxis Inc
F:FAD2
|
US |
|
Caihong Display Devices Co Ltd
SSE:600707
|
CN |
|
I
|
Inter Gamma Investment Company Ltd
TASE:INTR
|
IL |
|
C
|
Clarent Corp
OTC:CLRN
|
US |
|
H
|
Hangzhou Sf Intra-City Industrial Co Ltd
HKEX:9699
|
CN |
|
H
|
Hershey Co
XBER:HSY
|
US |
|
M
|
MedSci Healthcare Holdings Ltd
HKEX:2415
|
CN |
|
D
|
Daeyang Paper MFG Co Ltd
KOSDAQ:006580
|
KR |
|
CIM Real Estate Finance Trust Inc
OTC:CMRF
|
US |
|
S
|
Suoxinda Holdings Ltd
HKEX:3680
|
CN |
|
Biocept Inc
OTC:BIOCQ
|
US |
|
H
|
Huarchi Global Group Holdings Ltd
HKEX:2296
|
MO |
|
I
|
International Housewares Retail Co Ltd
HKEX:1373
|
HK |
Balance Sheet
Balance Sheet Decomposition
Advaxis Inc
Advaxis Inc
Balance Sheet
Advaxis Inc
| Oct-2014 | Oct-2015 | Oct-2016 | Oct-2017 | Oct-2018 | Oct-2019 | Oct-2020 | Oct-2021 | Oct-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
18
|
67
|
113
|
24
|
44
|
32
|
25
|
42
|
25
|
5
|
|
| Cash Equivalents |
18
|
67
|
113
|
24
|
44
|
32
|
25
|
42
|
25
|
5
|
|
| Short-Term Investments |
0
|
46
|
39
|
46
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
2
|
2
|
3
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
1
|
1
|
5
|
7
|
6
|
4
|
3
|
2
|
1
|
2
|
|
| Total Current Assets |
21
|
115
|
160
|
81
|
51
|
36
|
28
|
43
|
26
|
8
|
|
| PP&E Net |
0
|
1
|
4
|
7
|
7
|
4
|
7
|
0
|
0
|
1
|
|
| PP&E Gross |
0
|
1
|
4
|
7
|
7
|
4
|
7
|
0
|
0
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
1
|
2
|
3
|
2
|
0
|
0
|
1
|
|
| Intangible Assets |
3
|
3
|
4
|
5
|
5
|
5
|
3
|
3
|
0
|
4
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
|
| Total Assets |
23
N/A
|
120
+411%
|
169
+41%
|
94
-45%
|
62
-33%
|
45
-27%
|
39
-15%
|
47
+22%
|
26
-45%
|
17
-36%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
1
|
2
|
5
|
6
|
1
|
0
|
0
|
0
|
6
|
|
| Accrued Liabilities |
1
|
2
|
9
|
6
|
3
|
0
|
2
|
1
|
1
|
7
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
17
|
10
|
15
|
3
|
1
|
7
|
1
|
12
|
|
| Total Current Liabilities |
3
|
4
|
28
|
21
|
23
|
5
|
3
|
8
|
2
|
25
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
|
| Other Liabilities |
0
|
0
|
22
|
19
|
15
|
1
|
5
|
0
|
0
|
8
|
|
| Total Liabilities |
3
N/A
|
4
+48%
|
50
+1 143%
|
39
-21%
|
38
-3%
|
6
-85%
|
8
+46%
|
8
-5%
|
2
-71%
|
41
+1 682%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
87
|
134
|
208
|
301
|
368
|
384
|
411
|
429
|
443
|
197
|
|
| Additional Paid In Capital |
108
|
250
|
327
|
355
|
392
|
424
|
441
|
467
|
467
|
173
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
21
N/A
|
116
+461%
|
119
+3%
|
54
-54%
|
24
-56%
|
40
+64%
|
30
-24%
|
39
+29%
|
24
-39%
|
24
N/A
|
|
| Total Liabilities & Equity |
23
N/A
|
120
+411%
|
169
+41%
|
94
-45%
|
62
-33%
|
45
-27%
|
39
-15%
|
47
+22%
|
26
-45%
|
17
-36%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
12
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|